Intellectual Property and Business Development Committee

The MaineHealth Intellectual Property and Business Development Committee is appointed by the Chief Academic Officer with approval from the MaineHealth Chief Executive Officer, MaineHealth President and Maine Medical Center President.

The Committee is responsible for the following:

  • Making recommendations on whether and/or how much of MaineHealth resources to invest to support the development of an invention
  • When to license, to whom, and for how much: or to sell outright, if possible.
  • Whether to take ownership position in a company that will develop/market as part of license fee

Intellectual Property and Business Development Committee

Susan Ahern
VP of Innovation, MaineHealth

Joe Bohan
CEO, Scidose

Brady Bohrmann
Managing Director, Avalon Ventures

Tom Gridley, PhD
Faculty Scientist III, MaineHealth Institute for Research

Robert King
Former Investor, Goldman Sachs

Dan Nigrin, MD
Chief Information Officer, MaineHealth

Rich Parker, MS, CBET
VP of Business Development, Schivo Medical

Al Swallow III
Chief Financial Officer, MaineHealth

Robert Rubinowitz, CHDA
Sr. Director of Revenue Cycle Business Intelligence, MaineHealth

Stuart Watson
Entrepreneur & Board of Trustees member, Maine Medical Center & MaineHealth

David Yarin
Alliance Manager, Music Partnerships, MedRhythms, Inc.